Gao and colleagues observed in different murine tumor models higher expression of CTLA-4 in intermediate ILC1s (intILC1s, being CD49a+CD49b+EOMES+), that are impaired in their ability to secrete IFN-γ but not TNF-α [144] (Table 1). The gene discussed is IFNG; the disease is neoplasm.